PSAMP
HUMAW icon

P. Schoenfeld Asset Management (PSAM)’s Humacyte Inc Warrant HUMAW Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,155
Closed -$11.5K – 112
2023
Q1 		$11.5K Hold
19,155
– – ﹤0.01% 122
2022
Q4 		$7.52K Hold
19,155
– – ﹤0.01% 172
2022
Q3 		$22K Hold
19,155
– – ﹤0.01% 234
2022
Q2 		$17K Hold
19,155
– – ﹤0.01% 308
2022
Q1 		$37K Hold
19,155
– – ﹤0.01% 364
2021
Q4 		$44K Hold
19,155
– – ﹤0.01% 381
2021
Q3 		$55K Hold
19,155
– – ﹤0.01% 337
2021
Q2 		$54K Sell
19,155
-42,771
-69% -$113K ﹤0.01% 340
2021
Q1 		$180K Buy
+61,926
New +$146K 0.01% 282

Other funds holding HUMAW

JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s HUMAW Position: Q2 2023 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Humacyte Inc Warrant (HUMAW) in Q2 2023, closing a stake of 19,155 shares — an estimated $11.5K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in HUMAW in Q1 2021 and held it in 9 quarters. The position peaked at $180K in Q1 2021. 8 funds tracked by Wall St. Rank hold HUMAW as of Q2 2023.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Humacyte Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 19,155 Humacyte Inc Warrant shares in Q2 2023, an estimated $11.5K.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Humacyte Inc Warrant in Q1 2021 and held it in 9 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Humacyte Inc Warrant position peaked at $180K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2023.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2023, filed 11 Aug 2023.